IDO1 and familial pancreatic carcinoma: In this study, we focused on IDO-1 and -2, which are described to be overexpressed in some pancreatic cancer cells [54,55], and their influence on Vγ9Vδ2 γδ T cell cytotoxicity against PDAC cells and their consequences for their application in immunotherapy.